Independence Bank of Kentucky’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Independence Bank of Kentucky's VRTX Position: Q2 2026 in Review
Independence Bank of Kentucky increased its Vertex Pharmaceuticals (VRTX) stake by 405% in Q2 2026, buying an estimated $1.6M and bringing the position to 4,504 shares worth $2.24M. The position accounts for 0.25% of the portfolio, ranked #80.
Independence Bank of Kentucky first reported a position in VRTX in Q1 2018 and has held it in 14 quarters since. 1,296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Independence Bank of Kentucky held 4,504 shares of Vertex Pharmaceuticals worth $2.24M as of Q2 2026.
- Independence Bank of Kentucky bought 3,613 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.6M.
- Vertex Pharmaceuticals made up 0.25% of Independence Bank of Kentucky's portfolio in Q2 2026, its #80 holding.
- Independence Bank of Kentucky first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 14 quarters since.
- 1,296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.